comparemela.com
Home
Live Updates
Amgens Bkemv Approved As First Interchangeable Biosimilar To Soliris : comparemela.com
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris
THOUSAND OAKS (dpa-AFX) - The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British
Related Keywords
United Kingdom ,
British ,
Sarah Yim ,
Amgen Inc ,
Office Of Therapeutic Biologics ,
Alexion Pharmaceuticals ,
More Such Health News ,
Drug Administration ,
Rare Disease ,
Bkemv Risk Evaluation ,
Mitigation Strategy ,
Therapeutic Biologics ,
Drug Evaluation ,
Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.